4//SEC Filing
Siu Christine 4
Accession 0000899243-19-028027
CIK 0001731831other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 9:00 PM ET
Size
18.0 KB
Accession
0000899243-19-028027
Insider Transaction Report
Form 4
Siu Christine
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2019-11-21$0.59/sh+25,000$14,750→ 61,470 total - Sale
Common Stock
2019-11-21$56.00/sh−200$11,200→ 36,470 total - Sale
Common Stock
2019-11-21$55.12/sh−24,800$1,366,877→ 36,670 total - Sale
Common Stock
2019-11-22$55.29/sh−601$33,232→ 36,470 total - Sale
Common Stock
2019-11-22$54.71/sh−9,399$514,224→ 37,071 total - Exercise/Conversion
Stock Option (right to buy)
2019-11-21−25,000→ 192,191 totalExercise: $0.59Exp: 2027-12-21→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-11-21−10,000→ 182,191 totalExercise: $0.59Exp: 2027-12-21→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2019-11-22$0.59/sh+10,000$5,900→ 46,470 total
Footnotes (4)
- [F1]Represents the weighted average sale price of the shares sold from $55.00 to $55.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents the weighted average sale price of the shares sold from $54.21 to $55.19 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average sale price of the shares sold from $55.21 to $55.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Documents
Issuer
Eidos Therapeutics, Inc.
CIK 0001731831
Entity typeother
Related Parties
1- filerCIK 0001743029
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 9:00 PM ET
- Size
- 18.0 KB